PTC Therapeutics, Inc. PTCT
59.97 USD -4.49 -6.97%
At close · Oct 30
61.55 +1.58 +2.63%
After hours · Oct 30, 4:00 PM ET
58.80 52-week range 90.87
- YTD
- -21.05%
- 1 year
- -11.95%
- Open
- 64.75
- Prev close
- 64.46
- Mkt cap
- 5.01B
- Vol
- 2.36M
- Avg vol
- 1.06M
- EPS
- -1.47
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 59.65
- High
- 65.34
- Forward P/E
- 25.30
- Beta
- 0.49
- Short ratio
- 6.38
- Inst. own
- 122.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 18, 2027
- 50-d avg
- 65.57
- 200-d avg
- 70.76
- 1y target
- 97.80
MAX chart
Chart tools
Chart is warming up
The all-time price history for PTCT has not been loaded yet. Try again in a moment.
Altman Z-Score
0.74 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E 8.9×
P/S 3.5×
P/B -29.4×
P/FCF 14.7×
EV/EBITDA 8.7×
EV/Sales 4.5×
FCF Yield 6.8%
Gross Margin 95.9%
Operating Margin 49.5%
Net Margin 39.4%
ROE -332.5%
ROIC 33.4%
ROA 23.5%
Revenue 114.5%
Operating Income 383.1%
EPS (diluted) 264.5%
Free Cash Flow 326.0%
Current Ratio 2.3×
Quick Ratio 2.3×
Debt / Equity -13.2×
Net Debt / EBITDA 1.9×
Interest Coverage 5.6×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31